Sexual sequelae of general medical disorders

Lancet

Volumn 369, Issue 9559, 2007, Pages 409-424

  Basson, Rosemary ^a   Weijmar Schultz, Willibrord ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANGIOTENSIN II ANTAGONIST; ANTIANDROGEN; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BROMOCRIPTINE; CYPROTERONE ACETATE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROPOIETIN; ESTROGEN; ETIRACETAM; FLUTAMIDE; GONADORELIN AGONIST; LAMOTRIGINE; MIRTAZAPINE; MOCLOBEMIDE; NARCOTIC AGENT; NEUROLEPTIC AGENT; OXCARBAZEPINE; PROGESTERONE; REBOXETINE; SEROTONIN UPTAKE INHIBITOR; SPIRONOLACTONE; TESTOSTERONE; TIANEPTINE; ZINC;

ANEMIA; CHRONIC DISEASE; DEFORMITY; DRUG MEGADOSE; DYSPAREUNIA; EJACULATION; ERECTILE DYSFUNCTION; FATIGUE; HUMAN; HYPERPROLACTINEMIA; LUBRICATION; MEDICAL ASSESSMENT; MULTIPLE CYCLE TREATMENT; ORGASM; ORGASM DISORDER; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SELF CONCEPT; SEXUAL AROUSAL; SEXUAL AROUSAL DISORDER; SEXUAL DYSFUNCTION; SEXUAL FUNCTION;

EID: 33846577806     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(07)60197-4     Document Type: Review

References (177)

1. Gray H. Gray's Anatomy: the classic collector's edition. In: Pick T., and Howden R. (Eds) (1977), Bounty Books, New York 650
2. Wschiansky F., Chatton D., Lalive J., and Pause C. Troubles érectiles: place de l'ensemble organique et psychologique. [Erectile dysfunction: the place of the organic and the psychologic.]. Med Hyg 62 (2004) 591-598
3. Basson R. Human sex response cycles. J Sex Marital Ther 27 (2001) 33-43
4. Black P. Stress and the inflammatory response: a review of neurogenic inflammation. Brain Behav Immun 16 (2002) 622-653
5. Redouté J., Stoléru S., Pugeat M., et al. Brain processing of visual sexual stimuli in treated and untreated hypogonadal patients. Psychoneuro Endocrinol 30 (2005) 461-482
6. Stoléru S., Redouté J., Costes N., et al. Brain processing of visual sexual stimuli in men with hypoactive sexual desire disorder. Psychiatry Res 124 (2003) 67-86
7. Montorsi F., Perani D., Anchisi D., et al. Brain activation patterns during video sexual stimulation following the administration of apomorphine: Results for placebo-controlled study. Eur Urol 43 (2003) 405-411
8. Hawton K., and Catalan J. Prognostic factors in sex therapy. Behav Res Ther 24 (1986) 377-385
9. Cranston-Cuebas M., and Barlow D. Cognitive and affective contributions to sexual functioning. Ann Rev Sex Res 1 (1990) 119-161
10. van Lunsen R., and Laan E. Genital vascular responsiveness in sexual feelings in midlife women: psychophysiologic, brain, and genital imaging studies. Menopause 11 (2004) 741-748
11. Meston C. Why humans have sex. Arch Sex Behav (2006) (in press)
12. Cain V., Johannes C., Avis N., et al. Sexual functioning and practices in multi-ethnic study of midlife women: baseline results from SWAN. J Sex Res 40 (2003) 266-276
13. Basson R., Leiblum S., Brotto L., et al. Definitions of women's sexual dysfunction reconsidered: advocating expansion and revision. J Psychom Obstet Gynaecol 24 (2003) 221-229
14. Althof S., Dean J., Derogates L., Rosen R., and Sisson M. Current perspectives on the clinical assessment and diagnosis of female sexual dysfunction and clinical studies of potential therapies: a statement of concern. J Sex Med 2 (2005) 146-153
15. Rosen R. Assessment of sexual dysfunction in patients in benign prostatic hypoplasia. BJU Int 97 (2006) 29-33
16. Solomon H., Man J., Wierzbicki A., and Jackson G. Relation of erectile dysfunction to angiographic coronary artery disease. Am J Cardiol 91 (2003) 230-231
17. Blumentals W., Gomez-Camninero A., Joo S., and Bannappagari V. Should erectile dysfunction be considered as a marker for acute myocardial infarction? Results from a retrospective cohort study. Int J Impot Res 16 (2004) 350-353
18. Kaiser D., Billups K., Mason C., Wetterling R., Lundberg J., and Bank A. Impaired brachial artery endothelium -dependent and -independent vasodilatation in men with erectile dysfunction and no other clinical cardiovascular disease. J Am Col Cardiol 43 (2004) 179-184
19. Guirao Sanchez L., Garci-Giralda Ruiz L., Sandoval Martinez C., and Mocciaro Loveccio A. Erectile dysfunction in primary care as possible marker of health status: associated factors and response to sildenafil. Aten Primaria 30 (2002) 290-296
20. Van Lankveld J., and Grotjohann Y. Psychiatric comorbidity in heterosexual couples with sexual dysfunction assessed with the composite international diagnostic interview. Arch Sex Behav 29 (2000) 479-498
21. Soykan A., Boztas H., Kutlay S., et al. Do sexual dysfunctions get better during dialysis? Results of a six-month prospective follow-up study from Turkey. Int J Impot Res 17 (2005) 359-363
22. Enzlin P., Mathieu C., Van den Bruel A., Bosteels J., van der Schueren D., and Demyttenaere K. Sexual dysfunction in women with type I diabetes. Diabetes Care 25 (2002) 672-677
23. Zivadinov R., Zorzon M., Locatelli L., et al. Sexual dysfunction in multiple sclerosis: a MRI neurophysiological and urodynamic study. J Neurol Sci 210 (2003) 73-76
24. Perkins D. Predictors of noncompliance in patients with schizophrenia. J Clin Psychiatry 63 (2002) 1121-1128
25. Meuleman E., and van Lankveld J. Hypoactive sexual desire disorder: an underestimated condition in men. BJU Int 95 (2005) 291-298
26. Avis N., Zhao X., Johannes C., Ory M., Brockwell S., and Greendale G. Correlates of sexual function among multi-ethnic middle-aged women: results from the study of women's health across the nation (SWAN). Menopause 12 (2005) 385-398
27. Kennedy S., Dickens S., Eisfeld B., and Bagby R. Sexual dysfunction before antidepressant therapy in major depression. J Affect Disord 56 (1999) 2001-2008
28. Bonierbale M., Lancon C., and Tignol J. The ELIXIR study: evaluation of sexual dysfunction in 4,557 depressed patients in France. Curr Med Res Opin 19 (2003) 1114-1124
29. Montejo A., Llorca G., Izquierdo J., and Rico-Villademoros F. Incidence of sexual dysfunction-associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. J Clin Psychiatry 62 (2001) 10-21
30. Clayton A., Zajeck A., Ferguson J., Filipiak-Reisner J., Brown M., and Schwartz G. Lack of sexual dysfunction with the selective noradrenalin reuptake inhibitor reboxetine during therapy for major depressive disorder. Int Clin Psychopharmacol 18 (2003) 151-156
31. Croft H., Settle Jr E., Houser T., Batey S., Donahue R., and Ascher J. A placebo-controlled comparison of the efficacy and effects on sexual functioning of sustained- release bupropion and sertraline. Clin Ther 21 (1999) 643-658
32. Drory Y., Karvetz S., and Weingarten M. First acute myocardial infarction: comparison of sexual activity of women and men after first acute myocardial infarction. Am J Cardiol 85 (2000) 1283-1287
33. Yildiz H., and Pinar R. Sexual dysfunctions in patients with myocardial infarction. Anadolu Kardiyoloji Dergisi 4 (2004) 309-317
34. Servoss S., Januzzi J., and Muller J. Triggers of acute coronary syndromes. Cardiovasc Dis 44 (2002) 369-380
35. Kostis J., Jackson G., Rosen R., et al. Sexual dysfunction and cardiac risk (the second Princeton Consensus Conference). Am J Cardiol 96 (2005) 313-321
36. Rosano G., Marazzi G., Patrizi R., et al. Comparison of trimetazidine plus sildenafil to chronic nitrates in the control of myocardial ischemia during sexual activity in patients with coronary artery disease. Am J Cardiol 95 (2005) 327-331
37. Friedman S. Cardiac disease, anxiety, and sexual functioning. Am J Cardiol 86 (2000) 46-50
38. Steele T., Wuerth D., Finkelstein S., et al. Sexual experience of the chronic peritoneal dialysis patient. J Am Soc Nephrol 8 (1996) 1165-1168
39. Zamd M., Farh M., Zabari M., et al. Sexual dysfunction amongst 68 Moroccan male hemodialysis patients: clinical and endocrine study. Ann Endocrinol 65 (2004) 194-200
40. Palmer B. Sexual dysfunction in men and women with chronic kidney disease in end-stage kidney disease. Adv Renal Replace Ther 10 (2003) 48-60
41. San-Chiang W., Sho-Lin L., and Fu-Rong J. Influence of erythropoietin treatment on gonadotropic hormone levels on sexual function in male uremic patients. Scand J Urol Nephrol 35 (2001) 136-140
42. Peng Y., Chiang C., Kao T., et al. Sexual dysfunction in female hemodialysis patients: a multi-centre study. Kidney Int 68 (2005) 760-765
43. Salonia A., Zanni G., Nappi R., et al. Sexual dysfunction is common in women with lower urinary tract symptoms and urinary incontinence: results from cross-sectional study. Eur Urol 45 (2004) 642-648
44. Handa V., Harvey L., Cundiff G., et al. Sexual function among women with urinary incontinence and pelvic organ prolapse. Am J Obstet Gynecol 191 (2004) 751-757
45. Rogers G., Villarreal A., Kammerer-Doak D., and Qualls C. Sexual function in women with and without urinary incontinence and/or pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysf 12 (2001) 361-365
46. Grady D., Brown J., Vittingoffe, et al. Postmenopause hormones and incontinence: the heart and estrogen/progestin replacement study. Obstet Gynecol 97 (2001) 116-120
47. Eriksen B. A randomized, open, parallel group study of preventive effect of an estradiol-releasing ring (Estring) on recurrent urinary tract infections in postmenopausal women. Am J Obstet Gynecol 180 (1999) 1072-1079
48. Bhasin S., Enzlin P., Coviello A., and Basson R. Sexual dysfunction in men and women with endocrine disorders. Lancet (2006) (in press)
49. Kadioglu P., Yalin A., Tiryakiodlu O., et al. Sexual dysfunction in women with hyperprolactinemia: a pilot study report. J Urol 174 (2005) 1921-1925
50. Buster J., Kingsberg S., Aguirre O., et al. Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial. Obstet Gynecol 105 (2005) 944-952
51. Braunstein G., Sundwall D., Katz M., et al. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women. Arch Intern Med 165 (2005) 1158-1189
52. Simon J., Braunstein G., Nachtigall L., et al. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. J Clin Endocrinol Metab 90 (2005) 5226-5233
53. Davis S., van der Mooren M., van Lunsen R., et al. The efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women. Menopause 13 (2006) 387-396
54. Arlt W., Callies F., Van Vlijmen J., et al. Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med 341 (1999) 1013-1020
55. Rees P., Fowler C., and Maas K. Sexual dysfunction in neurological disorders. Lancet 369 (2006) 512-525
56. Knegtering H., Boks M., Blijd C., Castelein S., van den Bosch R., and Wiersman D. A randomized open label comparison of the impact of olanzapine versus risperidone on sexual functioning. J Sex Marital Ther 32 (2006) 315-326
57. MacDonald S., Halliday J., MacEwan T., et al. Nithsdale schizophrenia surveys 24: sexual dysfunction. Case controlled-study. Br J Psychiatry 182 (2003) 50-56
58. Atmaca M., Kuloglu M., and Tezcan E. A new atypical antipsychotic: quetiapine-induced sexual dysfunctions. Int J Impot Res 417 (2005) 201-203
59. Kodesh A., Weizman A., Aizenberg D., Hermesh H., Gelkopf M., and Zemishlany Z. Selegiline in the treatment of sexual dysfunction in schizophrenic patients maintained on neuroleptics: a pilot study. Clin Neuropharmacol 26 (2003) 193-195
60. Fogari R., Zoppi A., Corradi, et al. Sexual function in hypertensive males treated with lisinopril or atenolol: a cross-over study. Am J Hypertens 11 (1998) 1244-1247
61. Fogari R., Preti P., Derosa G., et al. Effective antihypertensive treatment with valsartan or atenolol on sexual activity and plasma testosterone in hypertensive men. Eur J Clin Pharmacol 8 (2002) 177-180
62. Fogari R., Preti P., and Zoppi A. Effect of valsartan and atenolol on sexual behaviour in hypertensive postmenopausal women. Am J Hypertens 17 (2005) 77-81
63. Nurnberg H., Hensley P., Gelenverg A., Fava M., Lauriello J., and Paine S. Treatment of antidepressant-associated sexual dysfunction with sildenafil: A randomized controlled trial. JAMA 2891 (2003) 56-64
64. Taylor M., Rudkin L., and Hawton K. Strategies for managing antidepressant-induced sexual dysfunction: systematic review of randomized controlled trials. J Affect Disord 88 (2005) 241-254
65. Bergmark K., Åvall-Lundqvist, Dickman P., Steineck G., and Henningsohn L. Synergy between sexual abuse and cervical cancer in causing sexual dysfunction. J Sex Marital Ther 31 (2005) 361-383
66. Brandenburg U., Leeners B., Schulte-Wefers H., Krahl D., and Rath W. Sexuality in gynecology? Analysis of the interaction between sexual and gynecological problems. Geburtsh Frauenheilk 62 (2002) 1-4
67. Bancroft J., Loftus J., and Longe J. Distress about sex: a national survey of women in heterosexual relationships. Arch Sex Behav 32 (2003) 193-211
68. Basson R. Female sexual response: the role of drugs in the management of sexual dysfunction. Obstet Gynecol 98 (2001) 350-352
69. Hartmann U., Heiser K., Rüffer-Hesse C., and Kloth G. Female sexual desire disorders: subtypes, classification, personality factors, and new directions for treatment. World J Urol 20 (2002) 79-88
70. Kukkonen T., Paterson L., Binik Y., Amsel R., Bouvier F., and Khalifé S. Convergent and discriminant validity of clitoral colour doppler ultrasonography as a measure of female sexual arousal. J Sex Marital Ther 32 (2006) 281-287
71. Maravilla K., Cao Y., Heiman J., et al. Serial MR imaging with MS-325 for evaluating female sexual arousal response: determination of intra-subjective reproducibility. J Magn Reson Imaging 18 (2003) 216-224
72. Chivers M., and Bailey J. A sex difference in features that elicit genital response. Biol Psychol 70 (2005) 115-120
73. Karama S., Lecours A., Leroux J., et al. Areas of brain activation in males and females during viewing of erotic film excerpts. Hum Brain Map 16 (2002) 1-13
74. Hamann S., Herman R., Nolan C., and Wallen K. Men and women differ in amygdala response to visual sexual stimuli. Nat Neurosci 7 (2004) 411-416
75. de Tejada I., Angulo J., Cellek S., et al. Physiology of erectile function. J Sex Med 1 (2004) 254-265
76. Goldstein I. Female sexual arousal disorder: new insights. Int J Impot Res 12 (2000) 152-157
77. Montorsi F., Briganti A., Salonia A., et al. Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease. Eur Urol 44 (2003) 360-365
78. Darby C., Mohr B., Goldstein I., Feldman H., Johannes C., and McKinlay J. Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk?. Urol 56 (2000) 302-306
79. Montorsi F., Salonia A., Deho F., et al. Pharmacological management of erectile dysfunction. BJU Int 91 (2003) 446-454
80. Rosas S., Joffe M., Franklin E., et al. Prevalence and determinants of erectile dysfunction in hemodialysis patients. Kidney Int 59 (2001) 2259-2266
81. Musone D., Cindolo L., Altieri V., and Russo D. Erectile dysfunction in kidney transplanted patients. Minerva Urol Nefrol 655 (2003) 193-197
82. Vaziri N., Ni Z., Oveisi F., Ling K., and Pandian R. Enhanced nitric oxide inactivation and protein nitration by reactive oxygen species in renal insufficiency. Hypertension 39 (2002) 135-141
83. Bellinghieri G., Santoro G., Santoro D., et al. Ultra-structural changes of corpora cavernosa in men with erectile dysfunction in chronic renal failure. Semin Nephrol 24 (2004) 488-491
84. Sáenz de Tejada I., Angulo J., Cellek S., et al. Pathophysiology of erectile dysfunction. J Sex Med 2 (2005) 26-39
85. Bita G., Beolinghieri G., Trusso A., et al. Uremic autonomic neuropathy studied by spectral analysis of heart rate. Kidney Int 56 (1999) 232-237
86. Rosen R., Altawein J., Boyle P., et al. Lower urinary tract symptoms and male sexual dysfunction. The multinational survey of the aging male (MSAM-7). Eur Urol 44 (2003) 637-649
87. Giuliano F. Impact of medical treatments for benign prostatic hyperplasia on sexual function. BJU Int 97 suppl 2 (2006) 34-38
88. Taylor Jr. H. Sexual activity and the cardiovascular patient: guidelines. Am J Cardiol 84 (1999) 6-10
89. Bocchi E., Guimaraes G., Mocelin A., Bacal F., Bellotti G., and Ramires J. Sildenafil effects on exercise, neurohormonal activation and erectile dysfunction in congestive heart failure: a double-blind, placebo-controlled, randomized study followed by a prospective treatment for erectile dysfunction. Circulation 106 (2002) 1097-1113
90. Bacon C., Mittleman M., Kwachi I., Giovannucci E., Glasser D., and Rimm E. Sexual function in men older than 50 years of age: results from the health professionals' follow-up study. Ann Intern Med 139 (2003) 161-168
91. Braun M., Wassmer G., Klotz T., et al. Epidemiology of erectile dysfunction: results of the "Cologne" male survey. Int J Impot Res 12 (2000) 305-311
92. Akkus E., Kodioglu A., Esen A., et al. Prevalence and correlates of erectile dysfunction in Turkey: a population-based study. Eur Urol 41 (2002) 298-304
93. On Y., Kim C., Oh B., Lee M., and Park Y. Effects of angiotensin converting enzyme inhibitor and calcium antagonist on endothelial function in patients with essential hypertension. Hypertens Res 25 (2003) 365-371
94. Kloner R., Brown M., Prisant M., and Collins M. Effect of sildenafil in patients with erectile dysfunction taking antihypertensive therapy. Sildenafil study group. Am J Hypertens 14 (2001) 70-73
95. Kloner R. Cardiovascular effects of the three phosphodiesterase-5 inhibitors approved for the treatment of erectile dysfunction. Circulation 110 (2004) 3149-3155
96. Rendell M., Rajfer J., Wicker P., and Smith M. Sildenafil for erectile dysfunction in men with diabetes: a randomized controlled trial. JAMA 281 (1999) 421-426
97. Kalsi J., Ralph D., Thomas P., et al. A nitric-oxide releasing PDE5 inhibitor relaxes human corpus cavernosum in the absence of endogenous nitric oxide. J Sex Med 2 (2005) 53-57
98. Traish A., and Guay A. Are androgens critical for penile erections in humans? Examining the clinical and preclinical evidence. J Sex Med 3 (2006) 382-407
99. Seidman S., Roose S., Menza M., Shabsigh R., and Rosen R. Treatment of erectile dysfunction in men with depressive symptoms: results of a placebo-controlled trial with sildenafil citrate. Am J Psychiatry 15 (2001) 162330
100. Margel D., Cohen M., Livne P., and Pillar G. Severe but not mild obstructive sleep apnoea is associated with erectile dysfunction. Urology 63 (2004) 545-549
101. Perimenis P., Karkoulias K., Markous, et al. Erectile dysfunction in men with obstructive sleep apnea syndrome: a randomized study of the efficacy of sildenafil and continuous positive airway pressure. Int J Impot Res 16 (2004) 256-260
102. Düsing R. Sexual dysfunction in male patients with hypertension: influence of antihypertensive drugs. Drugs 65 (2005) 773-786
103. Ko D., Hebert P., Coffey C., Sedrakyan, Curtis, and Krumholz H. Beta blocker therapy and symptoms of depression, fatigue and sexual dysfunction. JAMA 288 (2002) 351-357
104. Franzen D., Metha A., Siefert N., Braun M., and Hopp H. Effects of beta-blockers on sexual performance in men with coronary heart disease: a prospective randomized and double-blinded study. Int J Impot Res 13 (2001) 348-351
105. Dossenbach M., Hodge A., Anders M., et al. Prevalence of sexual dysfunction in patients with schizophrenia: international variation and underestimation. Int J Neuropsychopharmacol 8 (2005) 195-201
106. Hultgren R., Sjogren B., Soderberg M., et al. Sexual function in women suffering from aortoiliac occlusive disease. Eur J Vasc Endovasc Surg 17 (1999) 306-312
107. Erol B., Tefekli A., Ozbey I., et al. Sexual dysfunction in type II diabetic females: a comparative study. J Sex Marital Ther 28 suppl 1 (2002) 55-62
108. Doruk E., Akabay E., Çayan S., Bozlu M., and Acar D. Effect of diabetes mellitus on female sexual function and risk factors. Arch Androl 51 (2005) 1-6
109. Duncan L., Lewis C., Jenkins P., and Pearson T. Does hypertension and its pharmacotherapy affect sexual function in women?. Am J Hypertens 13 (2000) 640-647
110. Toorians A., Janssen, Laan E., et al. Chronic renal failure in sexual functioning: clinical status versus objectively assessed sexual response. Nephrol Dial Transplant 12 (1997) 2654-2663
111. Kalogeraki A., and Tamiolakis D. Cigarette smoking and vaginal atrophy in postmenopausal women. In Vivo 10 (1996) 597-600
112. Pandit L., and Ouslander J. Postmenopausal vaginal atrophy and atrophic vaginitis. Am J Med Sci 314 (1997) 228-231
113. Dennerstein L., Dudley E., Hopper J., Guthrie J., and Burger H. A prospective population-based study of menopausal symptoms. Obstet Gynecol 96 (2000) 351-358
114. Gorodeski G., Hopfer U., Liu C., and Margles E. Estrogen acetified vaginal pH by up-regulation of proton secretion via the apical membrane of vagino-ectocervical epithelial cells. Endocrinology 146 (2005) 816-824
115. Mynderse L., and Minga M. Oral therapy for Peyronie's disease. Int J Impot Res 14 (2002) 340-344
116. Shei Dei Yang S., Chou Tsai Y., Chang Wu C., Ping Liu S., and Cheng Wang C. Highly potent and moderately potent topical steroids are effective in treating phimosis: a prospective randomized study. J Urol 173 (2005) 1361-1363
117. Lowe F., and Jarow J. Placebo controlled study of oral terbutaline and pseudoephedrine in the management of prostaglandin E1-induced prolonged erections. Urology 42 (1993) 51-54
118. Leiblum S., and Nathan S. Persistent sexual arousal syndrome: a newly discovered pattern of female sexuality. J Sex Marital Ther 27 (2001) 365-380
119. Alzate H. Vaginal eroticism and female orgasm: a current appraisal. J Sex Marital Ther 11 (1985) 271-284
120. Schiavi R., and Segraves R. The biology of sexual function. Psychiatr Clin North Am 18 (1995) 7-23
121. Bancroft J. The endocrinology of sexual arousal. J Endocrinol 186 (2005) 411-427
122. Komisaruk B., Whipple B., Crawford A., et al. Brain activation during vaginocervical self-stimulation and orgasm in women with complete spinal cord injury: fMRI evidence of mediation by the vagus nerves. Brain Res 1024 (2004) 77-88
123. Waldinger M., Zwinderman A., Schweitzer D., and Oliver B. Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: a systematic review and meta-analysis. Int J Impot Res 16 (2004) 369-381
124. Metz M., and Pryor J. Premature ejaculation. A psychophysiological approach for assessment and management. J Sex Marital Ther 26 (2000) 293-320
125. Elliott S., and Fluker M. Fertility options for men with ejaculatory disorders. J Soc Obstet Gynecol 22 (2000) 26-32
126. Nickel J., Narayan P., McKay J., and Doyle C. Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial. J Urol 171 (2004) 1594-1597
127. Safarinejad M. Safety and efficacy of tamsulosin in the treatment of painful ejaculation: a randomized, double blind placebo-controlled study. Int J Impot Res 18 (2006) 527-533
128. Mahallesi E., Deveci A., Uyar Y., Ozcakir H., Kizilkaya S., and Caglar H. Mode of delivery and pelvic floor muscle strength in sexual function after childbirth. Int J Gynecol Obstet 88 (2005) 276-280
129. Nickel J., Elhilali M., and Vallancien G. ALF-ONE Study Group. Benign prostatic hypoplasia (BPH) and prostatitis: prevalence of painful ejaculation in men with clinical BPH. BJU Int 95 (2005) 571-574
130. Glatt A., and Zinner S. The prevalence of dyspareunia. Obstet Gynecol 75 (1990) 433-436
131. Laumann E., Paik A., and Rosen R. Sexual dysfunction in the United States: prevalence and predictors. JAMA 281 (1999) 537-544
132. Danielsson I., Sjöberg I., Stenlund H., and Wikman M. Prevalence and incidence of prolonged and severe dyspareunia in women: results from a population study. Scand J Pub Health 31 (2003) 113-118
133. Fugl-Meyer A., and Sjogren Fugl-Meyer K. Sexual disabilities, problems and satisfaction in 18-74 year old Swedes. Scand J Sexol 2 (1999) 79-105
134. The North American Menopause Society. Amended report from the NAMS Advisory Panel on Postmenopausal Hormone Therapy. Menopause 10 (2003) 6-12
135. Weisberg E., Ayton R., Darling G., et al. Endometrial and vaginal effects of low dose estradiol delivered by vaginal ring or vaginal tablet. Climacteric 8 (2005) 83-92
136. Rymer J., Chapman M., and Fogelman I. The study of the effect of tibolone on the vagina in postmenopausal women. Maturitas 18 (1994) 127-133
137. Leiblum S., Bachmann G., and Kemmann E. Vaginal atrophy in the postmenopausal woman: the importance of sexual activity and hormones. JAMA 249 (1983) 2195-2198
138. Verit F., Verit A., and Yeni E. The prevalence of sexual dysfunction and associated risk factors in women with chronic pelvic pain: a cross-sectional study. Arch Gynecol Obstet 274 (2006) 297-302
139. Romans S., Belaise C., Martin J., Morris E., and Raffi A. Childhood abuse and later medical disorders in women. An epidemiological study. Psychother Psychosom 71 (2002) 141-150
140. Goswami D., Goswami R., Vanerjee U., et al. Pattern of Candida species isolated from patients with diabetes mellitus and vulvovaginal candidiasis and their response to single dose oral fluconazole therapy. J Infect 52 (2006) 111-117
141. Begeron S., Binik Y., Khalifé S., Pagidas K., and Glazer H. A randomized comparison group of cognitive behavioural therapy, surface electromyographic biofeedback, and vestibulectomy in the treatment of dyspareunia resulting from vulvovestibulitis. Pain 91 (2001) 297-306
142. Fall M., Baranowski A., Fowler C., et al. European Association of Urology guidelines on chronic pelvic pain. Eur Urol 46 (2004) 681-689
143. Van de Werf-Eldering M., and Batstra L. To cut or not to cut: treatment of vulvar vestibulitis syndrome. J Psychosom Obstet Gynaecol 25 (2004) 77-79
144. Basson R., Weijmar Schultz W., Binik Y., et al. Women's sexual desire and arousal disorders and sexual pain. In: Lue T., Basson R., Rosen R., Guiliano F., Khoury S., and Montorsi F. (Eds). Sexual medicine: sexual functions in men and women (2004), Health Publications, Paris 922-925
145. Foster D. Vulvar disease. Obstet Gynecol 100 (2002) 145-163
146. World Health Organization. European STD Guidelines 2001. Int J STD & AIDS 12 (2001) 1-107
147. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 55 (2006) 1-94
148. Weijmar Schultz W., and Van de Wiel H. Vulvar vestibulitis syndrome: care made to measure. J Psychosom Obstet Gynaecol 23 (2002) 5-6
149. Nadarajah S., Quek J., Rose G., and Edmonds D. Sexual function in women treated with dilators for vaginal agenesis. J Pediatr Adolesc Gynecol 18 (2005) 39-42
150. Harlow B., and Stewart E. A population-based assessment of chronic unexplained vulvar pain: have we underestimated the prevalence of vulvodynia?. J Am Med Women's Assoc 58 (2003) 82-88
151. Gerber S., Bongiovanni A., Ledger W., and Witkin S. A deficiency in interferon-alpha production in women with vulvar vestibulitis. Am J Obstet Gynecol 186 (2002) 361-364
152. Babula O., Danielsson I., Sjöberg I., et al. Altered distribution of mannose-binding lectin alleles at exon I codon 54 in women with vulvar vestibulitis syndrome. Am J Obstet Gynecol 191 (2004) 762-826
153. Foster D., Sazenski T., and Stodgell C. Impact of genetic variation in interleukin-1 receptor antagonist and melanocortin-1 receptor genes on vulvar vestibulitis syndrome. J Reprod Med 49 (2004) 503-509
154. Gerber S., Bongiovanni A., Ledger W., and Witkin S. Interleukin-1 beta gene polymorphism in women with vulvar vestibulitis syndrome. Eur J Obstet Gynecol Reprod Biol 26 (2003) 74-77
155. Westrom L., and Willen R. Vestibular nerve fibre proliferation in vulvar vestibulitis syndrome. Obstet Gynecol 91 (1998) 572-576
156. Bohm-Starke N., Hilliges M., Falcomer C., and Rylander E. Increased intraepithelial innervation in women with vulvar vestibulitis syndrome. Gynecol Obstet Invest 46 (1998) 256-260
157. Tympanidis P., Terenghi G., and Dowd P. Increased innervation of the vulval vestibule in patients with vulvodynia. Br J Dermatol 148 (2003) 1021-1027
158. Bornstein J., Goldschmid N., and Sabo E. Hyperinnervation and mast cell activation may be used as histopathologic diagnostic criteria for vulvar vestibulitis. Gynecol Obstet Invest 58 (2004) 171-178
159. Pukall C., Binik Y., Khalifé S., et al. Vestibular tactile and pain thresholds in women with vulvar vestibulitis syndrome. Pain 96 (2002) 163-175
160. Pukall C., Strigo I., Binik Y., et al. Neural correlates of painful genital touch in women with vulvar vestibulitis syndrome. Pain 115 (2005) 118-127
161. Giesecke J., Reed B., Haefner H., et al. Quantitative sensory testing in vulvodynia patients and increased peripheral pressure pain in women with vulvar vestibulitis. Obstet Gynecol 104 (2004) 126-133
162. Sarma A., Foxman B., Bayirli B., et al. Epidemiology of vulvar vestibulitis syndrome: an exploratory case-control study. Sex Transm Infect 75 (1999) 320-326
163. Smith E., Ritchie J., Galask R., Pugh E., and Ricks-McGillan J. Case-control study of vulvar vestibulitis risk associated with genital infections. Infect Dis Obstet Gynecol 10 (2002) 193-202
164. Robert C., and Kupper T. Inflammatory skin diseases, T cells and immune surveillance. N Engl J Med 341 (1999) 1817-1828
165. Ramirez De Knott H., McCormick T., et al. Cutaneous hypersensitivity to Candida albicans in idiopathic vulvodynia. Contact Dermatitis 53 (2005) 214-218
166. Holstege G. The emotional motor system in relation to the supraspinal control of micturition and mating behaviour. Behav Brain Res 92 (1998) 103-109
167. Schultz W., van Andel P., Sabelis S., and Mooyaart E. Magnetic resonance imaging of male and female genitals during coitus and female sexual arousal. BMJ 319 (1999) 1596-1600
168. Bohm-Starke N., Johannesson U., Hilliges M., et al. Decreased mechanical pain threshold in the vestibular mucosa of women using oral contraceptives: a contributing factor in vulvar vestibulitis?. J Reprod Med 49 (2004) 888-892
169. Pukall C., Baron M., Amsel R., Khalife S., and Binik Y. Tender point examination in women with vulvar vestibulitis syndrome. Clin J Pain 22 (2006) 601-609
170. Payne K., Binik Y., Amsel R., and Khalifé S. When sex hurts, anxiety and fear orient attention towards pain. Eur J Pain 9 (2005) 427-436
171. Granot M. Personality traits associated with perception of noxious stimuli in women with vulvar vestibulitis syndrome. J Pain 6 (2005) 166-173
172. Van Lankveld J., ter Kuile M., de Groot H., Melles R., Nefs J., and Zandbergen M. Cognitive-behavioral therapy for women with life-long vaginismus: a randomized waiting list controlled trial of efficacy. J Clin Consult Psychol 74 (2006) 168-178
173. Ter Kuile M., van Lankveld J., de Groot E., Melles R., Nefs J., and Zandbergen M. Cognitive-behavioral therapy for women with lifelong vaginismus: process and prognostic factors. Behav Res Ther 45 (2006) 359-373
174. De Lamater J., and Sill M. Sexual desire in later life. J Sex Res 42 (2005) 138-149
175. Weijmar Schultz W., Wiel H., Hahn D., and Driel van M. Sexuality and cancer in women. Annu Rev Sex Res 3 (1992) 151-200
176. Jonker-Pool G., Van de Wiel H., Hoekstra H., et al. Sexual functioning after treatment for testicular cancer-review and meta-analysis of 36 empirical studies between 1975-2000. Arch Sex Behav 30 (2001) 55-74
177. Fung M., Bettencourt R., and Barrett-Connor H. Heart disease risk factors predict erectile dysfunction 25 years later. J Am Coll Cardiol 43 (2004) 1405-1411